In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clotrimazolum [INN-Latin] Drug Master File in Korea (Clotrimazolum [INN-Latin] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clotrimazolum [INN-Latin]. The MFDS reviews the Clotrimazolum [INN-Latin] KDMF as part of the drug registration process and uses the information provided in the Clotrimazolum [INN-Latin] KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clotrimazolum [INN-Latin] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clotrimazolum [INN-Latin] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clotrimazolum [INN-Latin] suppliers with KDMF on PharmaCompass.